Sol-Gel Technologies Ltd. (SLGL)
79.32
-2.40
(-2.94%)
USD |
NASDAQ |
Aug 26, 16:00
79.32
0.00 (0.00%)
After-Hours: 19:07
Sol-Gel Technologies Total Liabilities (Quarterly) : 5.66M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 5.66M |
| March 31, 2026 | 7.144M |
| December 31, 2025 | 7.106M |
| September 30, 2025 | 8.562M |
| June 30, 2025 | 7.425M |
| March 31, 2025 | 6.891M |
| December 31, 2024 | 6.996M |
| September 30, 2024 | 8.275M |
| June 30, 2024 | 7.103M |
| March 31, 2024 | 7.26M |
| December 31, 2023 | 6.643M |
| September 30, 2023 | 6.736M |
| June 30, 2023 | 6.807M |
| March 31, 2023 | 4.981M |
| December 31, 2022 | 4.415M |
| September 30, 2022 | 3.814M |
| June 30, 2022 | 4.632M |
| March 31, 2022 | 5.934M |
| Date | Value |
|---|---|
| December 31, 2021 | 13.60M |
| September 30, 2021 | 11.38M |
| June 30, 2021 | 7.158M |
| March 31, 2021 | 6.552M |
| December 31, 2020 | 8.312M |
| September 30, 2020 | 9.183M |
| June 30, 2020 | 9.111M |
| March 31, 2020 | 9.684M |
| December 31, 2019 | 8.836M |
| September 30, 2019 | 9.311M |
| June 30, 2019 | 8.636M |
| March 31, 2019 | 9.023M |
| December 31, 2018 | |
| September 30, 2018 | 5.73M |
| June 30, 2018 | 4.809M |
| March 31, 2018 | 2.903M |
| December 31, 2017 | 68.01M |
| September 30, 2017 | 71.77M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Teva Pharmaceutical Industries Ltd. | 32.10B |
| RedHill Biopharma Ltd. | -- |
| MediWound Ltd. | 27.45M |
| Purple Biotech Ltd. | 1.953M |
| PolyPid Ltd. | 9.846M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 53.76M |
| Shareholders Equity (Quarterly) | 48.10M |
| Debt to Equity Ratio | 0.016 |
| Current Ratio | 10.37 |
| Net Debt Paydown Yield | 0.03% |